Concepedia

Publication | Closed Access

An Orally Administered Multitarget Tyrosine Kinase Inhibitor, SU11248, Is a Novel Potent Inhibitor of Thyroid Oncogenic RET/Papillary Thyroid Cancer Kinases

DOI

280

Citations

20

References

2006

Year

Dong Wook Kim, Young Suk Jo, Hye Sook Jung, Hyo Kyun Chung, Jung Hun Song, Ki Cheol Park, Su Hyeon Park, Jung Hwan Hwang, So Young Rha, Gi Ryang Kweon,
The Journal of Clinical Endocrinology & Metabolism

Abstract

SU11248 is a highly effective tyrosine kinase inhibitor of the RET/PTC oncogenic kinase.

References

YearCitations

Page 1